HPV vaccines for prevention of cervical pre-cancer in adolescent girls and women

Autores

  • Jia Jian Li Department of Emergency Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York, USA http://orcid.org/0000-0002-4446-9412
  • Jessica Stetz Department of Emergency Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York, USA

DOI:

https://doi.org/10.17267/2675-021Xevidence.v1i2.2510

Palavras-chave:

HPV, Vaccines, Cervical pre-cancer, cervical cancer, adolescent

Resumo

The evidence presented in this Cochrane meta-analysis shows the HPV vaccination confers significant benefit in preventing cervical pre-cancer. NNT of 60 for preventing one cervical pre-cancer (women 15 to 25 years old with or without HPV infection). The effect is higher for lesions associated with HPV16/18. The data also demonstrates an absence of serious adverse events. Therefore, we have assigned a color recommendation of Green (Benefit > Harm) to this vaccine.

Downloads

Os dados de download ainda não estão disponíveis.

Biografia do Autor

  • Jessica Stetz, Department of Emergency Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York, USA
    Attending Physiican in Emergency Medicine

Referências

Available at: https://www.cdc.gov/hpv/parents/vaccine.html. Last accessed November 12, 2018

Arbyn M, Xu L, Simoens C, Martin-Hirsch PPL. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No.: CD009069. DOI: 10.1002/14651858.CD009069.

Available at https://www.cancer.org/cancer/cancer-basics/lifetime-probability-of-developing-or-dying-from-cancer.html. Last accessed on November 30,2018

Unger E, Dillner J. Human Papillomavirus Laboratory Manual. 1st Edition. Geneva: WHO (Quality, Safety and Standards (QSS) team of the Department of Immunization, Vaccines and Biologicals), 2010.

Initiative for Vaccine Research of the Department of Immunization Vaccines and Biologicals (WHO). Human Papillomavirus (HPV) Vaccine Background Paper. World Health Organization (WHO) 2009:1–249.

Thompson SG, Sharp SJ. Explaining heterogeneity in meta- analysis: a comparison of methods. Statistics in Medicine 1999;18:2693–708.

Sharp S. Meta-analysis regression. Statistics Technical Bulletin 1998;7:148–55.

Available at: https://www.goodrx.com/gardasil-9?drug-name=gardasil+9. Last accessed December 1st, 2018.

Downloads

Publicado

21.10.2019

Edição

v. 1 n. 2 (2019)

Seção

Critical Appraisal of Evidence

Licença

The authors retain copyrights, transferring to the Journal of Evidence-Based Healthcare only the right of first publication. This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License

Como Citar

1.
Li JJ, Stetz J. HPV vaccines for prevention of cervical pre-cancer in adolescent girls and women. Evidence [Internet]. 21º de outubro de 2019 [citado 10º de julho de 2026];1(2):112-5. Disponível em: https://www5.bahiana.edu.br/index.php/evidence/article/view/2510